The invisible is made visible by the microscopes. Moreover, in comparison with the traditional light microscopes, transmission X-ray microscopes (TXM) can view through samples with considerably higher resolution, exhibiting extraordinary details. TXM is used by scientists across an extensive range of scientific domains to view the structural and chemical makeup of their samples ranging from biological cells to energy storage materials.
Currently, researchers at the National Synchrotron Light Source II (NSLS-II)—a U.S. Department of Energy (DOE) Office of Science User Facility at DOE’s Brookhaven National Laboratory—have created a TXM with the ability to image samples 10 times faster than was possible earlier. The study has been reported in Applied Physics Letters.
“We have significantly improved the speed of X-ray microscopy experiments,” stated Wah-Keat Lee, lead scientist at NSLS-II’s Full Field X-ray Imaging (FXI) beamline, where the microscope was developed. At FXI, Lee and his team members decreased the time taken by a TXM to image samples in 3D from more than 10 minutes to just 1 minute, while still forming images with excellent 3D resolution below 50 nm, or 50 billionths of a meter. “This breakthrough will enable scientists to visualize their samples much faster at FXI than at similar instruments around the world,” stated Lee. A faster TXM can not only decrease the time it takes to complete an experiment but can also gather more valuable data from samples.
The holy grail of almost all imaging techniques is to be able to see a sample in 3D and in real time. The speed of these experiments is relevant because we want to observe changes that happen quickly. There are many structural and chemical changes that happen on different time scales, so a faster instrument can see a lot more. For example, we have the ability to track how corrosion happens in a material, or how well various parts of a battery are performing.
Wah-Keat Lee, Lead Scientist, Full Field X-ray Imaging (FXI) beamline, NSLS-II
Image Credit: Brookhaven National Laboratory
News This Week
Within a day of testing positive for covid-19 in June, Miranda Kelly was sick enough to be scared. At 44, with diabetes and high blood pressure, Kelly, a certified nursing assistant, was having trouble [...]
A technology developed at Vanderbilt University Medical Center has led to the discovery of an "ultra-potent" monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant. The antibody [...]
Research has found a significant fall in levels of antibodies against SARS-CoV-2, the virus that causes COVID-19, 6 months after the second dose of the Pfizer-BioNTech vaccine. Clinical evidence also suggests that the risk [...]
Are the COVID vaccines substantially different from/inferior to other vaccines in terms of their effectiveness? The issue raised, and I'm mostly paraphrasing here, is this: Most vaccines (e.g. measles, smallpox) have efficacy defined such [...]
The EVONANO platform allows scientists to grow virtual tumors and use artificial intelligence to automatically optimize the design of nanoparticles to treat them. The ability to grow and treat virtual tumors is an [...]
Modern Approaches to Augmentation of Brain Function Available from Springer Press This book covers recent advances in neural technology that provide for enhancements for brain function. It addresses a broad range of neural phenomena [...]
Although the currently available COVID-19 vaccines are highly effective, limited manufacturing capacity and the need for cold-chain storage hinder their global distribution. A recent study tested the efficacy of a new adeno-associated virus (AAV) [...]
Fully vaccinated people were 11 times less likely to die of COVID and 10 times less likely to be hospitalized compared to the unvaccinated since highly contagious Delta became the most common variant, US [...]
The highly-infectious Delta coronavirus variant has spread to at least 174 countries worldwide, from the US to Australia, causing a surge in COVID-19 cases. The variant has mutations that help it partially escape the immune response produced by [...]
Fragile mRNA molecules used in COVID-19 vaccines can’t get into cells on their own. They owe their success to lipid nanoparticles that took decades to refine. Messenger RNA (mRNA) is having a moment. This [...]
The COVID-19 pandemic has revealed critical knowledge gaps and assumptions concerning how respiratory viruses spread between hosts. Traditionally thought to be spread mainly through large respiratory droplets produced by the coughs and sneezes of sick individuals, [...]
SARS-CoV-2 is just one of nonillions of viruses on our planet, and scientists are rapidly identifying legions of new species. Mya Breitbart has hunted novel viruses in African termite mounds, Antarctic seals and water [...]
As a team of South African researchers we have identified a new lineage of SARS-CoV-2, the virus causing COVID-19. A lineage represents a genetically distinct virus population with a common ancestor. This virus may be designated as a variant [...]